Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice.
about
Oligodendrogenesis in the normal and pathological central nervous systemAntidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depressionExperimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice.Reduced axonopathy and enhanced remyelination after chronic demyelination in fibroblast growth factor 2 (Fgf2)-null mice: differential detection with diffusion tensor imaging.Gene therapy in autoimmune, demyelinating disease of the central nervous system.Vectors for the treatment of autoimmune disease.Endogenous cell repair of chronic demyelination.Remyelinating and neuroprotective treatments in multiple sclerosis.Retroviral lineage analysis of fibroblast growth factor receptor signaling in FGF2 inhibition of oligodendrocyte progenitor differentiationGene therapy for autoimmune diseases: quo vadis?Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions.Growth factor regulation of remyelination: behind the growing interest in endogenous cell repair of the CNS.Systemic neurotransplantation--a problem-oriented systematic review.Signalling pathways that inhibit the capacity of precursor cells for myelin repair.Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology.Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration.The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseasesDysregulated fibroblast growth factor (FGF) signaling in neurological and psychiatric disorders.Extracellular cues influencing oligodendrocyte differentiation and (re)myelinationThe role of growth factors as a therapeutic approach to demyelinating disease.Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9.Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for glial and neural-related molecules in central nervous system mixed glial cell cultures: neurotrophins, growth factors and structural proteinsThe role of FGF2 in spinal cord trauma and regeneration researchThe virtues and vices of harnessing HSV vectors for CNS autoimmunity modulation.HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis.Co-Transplantation of Human Neurotrophic Factor Secreting Cells and Adipose-Derived Stem Cells in Rat Model of Multiple Sclerosis.Dynamics of oligodendrocyte responses to anterograde axonal (Wallerian) and terminal degeneration in normal and TNF-transgenic mice.Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects mice from experimental autoimmune encephalomyelitis through ERK/AKT phosphorylation.Growth factor treatment promotes mobilization of young but not aged adult subventricular zone precursors in response to demyelination.Autoantigen-pulsed dendritic cells constitute a beneficial cytokine and growth factor network in ameliorating experimental allergic encephalomyelitis.Regenerative Strategies for the Central Nervous System
P2860
Q21129352-2AE9BD3B-B2E6-471D-92DB-C92C5B7A5018Q30521434-A754C7BA-6882-4D0B-BB2C-202DA14DA458Q34192220-31D302B3-A5F9-4E27-A72B-0674AB73D833Q34769756-9D5BA13E-691E-4730-B893-67686FF5A4F5Q35122159-E2FD964E-352F-4D35-9BA0-726878FE3D99Q35122178-CADA958D-0786-4D36-AF67-3F5E9B8DE26BQ35129300-310C485E-49D3-4A77-A3F5-5C3ECAFAF0FAQ35753458-95E778D8-3599-44FF-8E32-B6AF9C307DEEQ35809314-7F98DECD-7483-475F-9BA7-0E8347EDAFD2Q35906093-D6D3D042-EF78-4125-891C-CECBE41F20E7Q35946418-5DE63240-C0EB-4529-9D23-A39F3AB76EF1Q37012791-7E1F27B7-73DB-4F69-91FE-B61EF78A430BQ37519562-033F321C-6378-43A4-899E-034F2BD8CD70Q38072291-96A9D5B8-0D6B-4587-B78F-E4E4AB80FEB6Q38108182-AA49CCF8-047D-48AD-88BE-A59C57CA93F6Q38140658-69033892-3BF4-4713-9F74-1295BC9377E7Q38175970-80671A31-FB8D-4009-9B3B-F9B002BE9E21Q38603624-93E04745-09AF-4915-AB09-57E5C066F210Q38789322-6BD9FF98-093C-440A-9233-157B81989170Q38789326-A4F373B1-4438-499D-9659-9E0B56FF794DQ41020735-7E6A0BC6-361E-4BA0-B11F-88DDF6D0AB1BQ41825402-B5B4A870-1266-4D4A-B7BB-544A7D26742BQ42391674-6A931B85-BDBA-4B91-87C3-E1079455E580Q43749965-6674FE7C-B85D-41AD-83CA-C4A76BFB42E1Q44673491-58DB1031-3AF0-453D-8076-9BA742F3BBB3Q45882279-DC1F7EE2-FFC5-4A56-A79A-E2C6B8805A87Q47225588-9AE840E5-08CD-4BDA-ABC2-4654DC2BF3ECQ48101557-3F3F811A-7C8A-4765-A615-CC981A5341F4Q48342467-3150330B-DE70-449E-9009-3BF5F7CC1EA3Q48495848-BCF7AC92-B6CB-48B0-A408-9E58645A712BQ53664851-CC31727B-A836-4446-8FBA-249E4A036FC7Q57460363-A1681415-9728-4E98-9EF6-2830BDCB2C27
P2860
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Fibroblast growth factor-II ge ...... phalomyelitis in C57BL/6 mice.
@en
type
label
Fibroblast growth factor-II ge ...... phalomyelitis in C57BL/6 mice.
@en
prefLabel
Fibroblast growth factor-II ge ...... phalomyelitis in C57BL/6 mice.
@en
P2093
P50
P356
P1433
P1476
Fibroblast growth factor-II ge ...... ephalomyelitis in C57BL/6 mice
@en
P2093
E Brambilla
J C Glorioso
P2888
P304
P356
10.1038/SJ.GT.3301523
P577
2001-08-01T00:00:00Z
P5875
P6179
1012333398